COG | Jotup

Quantum Dot Market worth $23.9 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on:

금요일, 5월 10, 2024

Cadmium-free quantum dots is expected to have the largest market size in the quantum dot market during the forecast period.

Key Points:

Cadmium-free quantum dots is expected to have the largest market size in the quantum dot market during the forecast period.
Due to the emergence of viable alternatives, manufacturers are transitioning extensively from cadmium-based quantum dots to cadmium-free quantum dots.
Asia Pacific is anticipated to register the highest CAGR in the quantum dot market during the forecast period.
Furthermore, accelerating developments and advancements in the quantum dot market is expected to further drive the market growth in the region.

Quantum Dot Market worth $23.9 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on:

금요일, 5월 10, 2024

Cadmium-free quantum dots is expected to have the largest market size in the quantum dot market during the forecast period.

Key Points:

Cadmium-free quantum dots is expected to have the largest market size in the quantum dot market during the forecast period.
Due to the emergence of viable alternatives, manufacturers are transitioning extensively from cadmium-based quantum dots to cadmium-free quantum dots.
Asia Pacific is anticipated to register the highest CAGR in the quantum dot market during the forecast period.
Furthermore, accelerating developments and advancements in the quantum dot market is expected to further drive the market growth in the region.

Ranking No.1, Unilumin Reshapes the Market Landscape of LED Video Wall Industry

Retrieved on:

목요일, 5월 9, 2024

MicroLED, COG, Lighting, RMB, LED, COB, MIP, Video game

SHENZHEN, China, May 9, 2024 /PRNewswire/ -- In its 20th anniversary year, Unilumin recorded remarkable business performance. It achieved a revenue of RMB 7.41 billion (+4.73% YoY), and a net profit of RMB 144 million (+127.06% YoY). On profitability, with an improvement in the gross margins of both domestic and overseas business, Unilumin's overall gross margin increased by 2% to 28.8%. On a revenue scale basis (LED video wall business alone), Unilumin won the title.

Key Points:

On a revenue scale basis (LED video wall business alone), Unilumin won the title.
Based on their unique market positioning, three brands have all penetrated various LED video wall segments.
Unilumin was the first to propose 'Metasight' concept in the industry, facilitating the integrated development of LED display and LED lighting .
On advanced LED technologies, Unilumin has conducted R&D work on COG and silicon-based Micro LED technologies, paving the way for its entry into the To C market.

Ranking No.1, Unilumin Reshapes the Market Landscape of LED Video Wall Industry

Retrieved on:

목요일, 5월 9, 2024

MicroLED, Multimedia, COG, Lighting, RMB, LED, COB, MIP, Video game

SHENZHEN, China, May 8, 2024 /PRNewswire/ -- In its 20th anniversary year, Unilumin recorded remarkable business performance. It achieved a revenue of RMB 7.41 billion (+4.73% YoY), and a net profit of RMB 144 million (+127.06% YoY). On profitability, with an improvement in the gross margins of both domestic and overseas business, Unilumin's overall gross margin increased by 2% to 28.8%. On a revenue scale basis (LED video wall business alone), Unilumin won the title.

Key Points:

On a revenue scale basis (LED video wall business alone), Unilumin won the title.
Based on their unique market positioning, three brands have all penetrated various LED video wall segments.
Unilumin was the first to propose 'Metasight' concept in the industry, facilitating the integrated development of LED display and LED lighting .
On advanced LED technologies, Unilumin has conducted R&D work on COG and silicon-based Micro LED technologies, paving the way for its entry into the To C market.

Valley Children's Receives Historic $15 Million Gift to Create Advanced Cell Therapy Program for Pediatric Cancer

Retrieved on:

금요일, 5월 3, 2024

Cancer, Bone marrow, Protein, Haematopoietic system, Hospital, Travel, Health care, Research, History, Weapon, Acute lymphoblastic leukemia, Accreditation, Transplant, Patient, Nursing, Infection, COG, San Francisco Bay Area, Vaccine

MADERA, Calif., May 3, 2024 /PRNewswire/ -- Valley Children's Healthcare this week announced a historic donation of $15 million that will significantly enhance the hospital's ability to provide the most advanced bone marrow transplant and chimeric antigen receptor (CAR) T-cell therapy treatments to kids with cancer in the Central Valley.

Key Points:

CAR T-cell therapy is an advanced genetically engineered therapy that uses the body's natural immune system to fight cancer and infections.
In a key CAR T-cell study in 2021, approximately 60% of children who underwent CAR T-cell therapy were cancer-free after five years.
The gift will support not only the establishment and accreditation of the program but also operational funding for its first 10 years.
"Because of this important donation, we will be able to establish a life-saving cellular and gene therapy program at Valley Children's.

Stacey Lasser of Mednet to Present at the 2nd Annual Clinical Outsourcing Group New England Conference in Boston

Retrieved on:

금요일, 4월 19, 2024

Culminating project, Conference, Patient, Lasser, COG, Clinical data management, Pharmaceutical industry

MINNEAPOLIS, April 19, 2024 /PRNewswire/ -- Mednet, a healthcare technology company, today announced Senior Project Manager Stacey Lasser will present at the 2nd Annual Clinical Outsourcing Group (COG) New England conference in Boston, Massachusetts from April 23 – 24, 2024.

Key Points:

MINNEAPOLIS, April 19, 2024 /PRNewswire/ -- Mednet, a healthcare technology company, today announced Senior Project Manager Stacey Lasser will present at the 2nd Annual Clinical Outsourcing Group (COG) New England conference in Boston, Massachusetts from April 23 – 24, 2024.
Additionally, Mednet returns as a conference partner and exhibitor at booth #37.
Lasser's presentation, "Technology Solutions for Enhancing Patient Engagement in Clinical Trials", is scheduled to take place at 11:55 am on April 23.
Based in Minnesota, Lasser has been serving Mednet customers for over 16 years from study startup through completion using the iMednet eClinical platform.

Liberty Gold Reports Year-End 2023 Financial and Operating Results

Retrieved on:

목요일, 3월 28, 2024

Mining, Biophysical environment, Inference, LGD, Gold, Sale, NSR, Table, COG, TSX, Social, OTCQX, Rare-earth element

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) ("Liberty Gold" or the “Company”), is pleased to announce its financial and operating results for the fiscal year ended December 31, 2023.

Key Points:

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) ("Liberty Gold" or the “Company”), is pleased to announce its financial and operating results for the fiscal year ended December 31, 2023.
On September 5, 2023, published second annual Environmental, Social and Governance report: Developing Gold Deposits in a Responsible and Sustainable Manner2.
On November 8, 2023, announced the appointment of Cal Everett as Chief Executive Officer and Jon Gilligan as President, effective November 10, 20233.
Completed 2023 RC exploration drilling program as of December 31, 2023, for a total of 27,461 meters drilled.

Hyundai Hope On Wheels Reaches a Lifetime Giving Milestone of a Quarter-Billion Dollars in 2024

Retrieved on:

수요일, 3월 27, 2024

Research, Health, Cole, Survival rate, Disease, Hyundai Motor America, Patient, Hospital, Children's Oncology Group, Cancer, Hope, Life, Organic, COG, Hyundai, Multimedia, Courage, National Youth, Estate (law)

With this commitment, the organization reaches a lifetime giving milestone of a quarter-billion dollars as part of its 26th anniversary.

Key Points:

With this commitment, the organization reaches a lifetime giving milestone of a quarter-billion dollars as part of its 26th anniversary.
"We are proud to have reached this incredible milestone for Hyundai Hope On Wheels, as it truly speaks to the commitment of Hyundai Motor America and its dealers to the cause of ending childhood cancer," said Kevin Reilly, vice chairman of the Hyundai Hope On Wheels Board of Directors, and president of Alexandria Hyundai.
Later this year, Hyundai Hope On Wheels will visit children's hospitals across the nation to present Hope On Wheels grant awards.
Primary funding for Hyundai Hope On Wheels comes from Hyundai Motor America and its more than 830 U.S. dealers.

Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results

Retrieved on:

목요일, 2월 29, 2024

RESEARCH TRIANGLE PARK, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced preliminary unaudited fourth quarter and full-year 2023 net revenues.

Key Points:

~ Company Expects to Report 2023 Fourth Quarter and Audited Full-Year Results on or about March 26, 2024 ~
RESEARCH TRIANGLE PARK, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced preliminary unaudited fourth quarter and full-year 2023 net revenues.
The information in this press release is based upon preliminary unaudited information and management estimates for the fourth quarter 2023 and is subject to the completion of Fennec’s financial closing procedures and year end audit.
Preliminary Unaudited 2023 Fourth Quarter Revenue and Year End Performance:
Fourth quarter 2023 net revenues are expected to be approximately $9.2 to $9.7 million, which represents approximately a 41-49% increase over the third quarter of 2023.
Fennec expects to report its 2023 fourth quarter and audited full-year year results of operations on or about March 26, 2024.

City of Hope Children’s Cancer Center, Children’s Oncology Group conduct largest clinical trial seeking to prevent heart failure among childhood cancer survivors

Retrieved on:

화요일, 1월 9, 2024

Physicians at City of Hope, one of the largest cancer research and treatment organizations in the United States, in cooperation with the Children’s Oncology Group (COG) , have conducted the largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure.

Key Points:

Physicians at City of Hope, one of the largest cancer research and treatment organizations in the United States, in cooperation with the Children’s Oncology Group (COG) , have conducted the largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure.
View the full release here: https://www.businesswire.com/news/home/20240109428042/en/
Physicians at City of Hope Children's Cancer Center, in cooperation with the Children’s Oncology Group (COG), have conducted the largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure.
Unfortunately, after the onset of heart function decline, the downward cascade is irreversible, highlighting an urgent need for early prevention strategies.
“The growing number of childhood cancer survivors makes the development of early interventions imperative.